指南与共识炎症性肠病食管胃疾病与幽门螺杆菌消化内镜

澳大利亚粪菌移植临床实践监管、生产与使用共识声明

Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice.
指南 / 共识 · Gut · 2020-02-11

该共识由24名多学科成员采用改良德尔菲法制定,针对粪菌移植(FMT)的供体筛选、临床适应证、生产标准及设施要求形成27条推荐。共识强调需规范供体评估与筛查、给药途径、治疗中心与粪库的最低标准,并指出近期FMT后死亡和败血症事件凸显了进一步监管的必要性。

要点

  • 共识形成27条推荐,覆盖供体筛选、给药途径、临床适应证及FMT生产与设施标准。
  • 供体筛查需包括临床选择标准、血液和粪便检测的最低要求。
  • FMT治疗设施需区分单一站点中心(如医院)与粪库的不同要求。

核心结论

  • 该共识为FMT的临床生产和使用提供了涵盖供体评估、生产标准、治疗设施和临床适应证的综合性推荐。

研究设计与样本

  • 24名多学科工作组通过在线投票和现场会议,采用改良德尔菲法基于最佳证据和专家意见制定推荐,证据采用GRADE系统评级。

主要发现

  • 共识达成27条推荐,包括供体筛选最低标准(临床选择标准、血液和粪便检测)、可接受的给药途径、临床适应证、FMT生产最低标准及治疗设施要求(区分单一站点中心与粪库),以及未来研究和产品开发建议。

关键数值与推荐

  • 供体筛查推荐包括临床选择标准、血液和粪便检测的最低标准。
  • FMT生产与治疗设施要求需区分单一站点中心(如医院)与粪库。
  • 推荐涉及可接受的给药途径和临床适应证。

临床怎么用

  • 临床开展FMT应遵循共识推荐的供体筛选、生产标准和设施要求,并根据中心类型(单一站点中心或粪库)满足相应条件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Faecal microbiota transplantation (FMT) has proved to be an extremely effective treatment for recurrent Clostridioides difficile infection, and there is interest in its potential application in other gastrointestinal and systemic diseases. However, the recent death and episode of septicaemia following FMT highlights the need for further appraisal and guidelines on donor evaluation, production standards, treatment facilities and acceptable clinical indications. DESIGN: For these consensus statements, a 24-member multidisciplinary working group voted online and then convened in-person, using a modified Delphi approach to formulate and refine a series of recommendations based on best evidence and expert opinion. Invitations to participate were directed to Australian experts, with an international delegate assisting the development. The following issues regarding the use of FMT in clinical practice were addressed: donor selection and screening, clinical indications, requirements of FMT centres and future directions. Evidence was rated using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. RESULTS: Consensus was reached on 27 statements to provide guidance on best practice in FMT. These include: (1) minimum standards for donor screening with recommended clinical selection criteria, blood and stool testing; (2) accepted routes of administration; (3) clinical indications; (4) minimum standards for FMT production and requirements for treatment facilities acknowledging distinction between single-site centres (eg, hospital-based) and stool banks; and (5) recommendations on future research and product development. CONCLUSIONS: These FMT consensus statements provide comprehensive recommendations around the production and use of FMT in clinical practice with relevance to clinicians, researchers and policy makers.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Haifer C, Kelly CR, Paramsothy S, et al. Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice. Gut. 2020. PMID: 32047093. doi:10.1136/gutjnl-2019-320260

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。